Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid-phase route enhances purity and yield for liposome drug carriers reducing production complexity significantly while ensuring scalable manufacturing processes for global pharmaceutical supply chains demanding high quality standards.
Patent CN112574285B reveals a novel solid-liquid phase synthesis for disulfide-bonded polypeptides, offering high purity and simplified manufacturing for pharmaceutical intermediates.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Patent CN104710509B reveals low-temperature solid-phase synthesis for over 99% purity Eptifibatide, ensuring supply chain stability and reduced impurities for global buyers.
Novel solid-liquid hybrid method for Semaglutide fragments improves yield to 49% and purity to 99.9%, ensuring reliable supply chain.
Patent CN108218957B details a novel hybrid synthesis for AMG416, offering improved purity and reduced environmental impact for reliable pharmaceutical intermediate supply chains.
Patent CN117186186A reveals a hybrid solid-liquid synthesis method for high-purity cyclic peptides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107827956A details solid-phase synthesis of Reniochalistatin E. Offers high purity and reduced racemization for reliable pharmaceutical intermediates supply chains.
Patent CN102020703A details a robust solid-phase synthesis for fatty acyl cyclic depsipeptides. This method offers high purity and scalability for antibiotic intermediate manufacturing.
Novel soluble solid-phase carrier technology reduces solvent waste and reactor size for scalable polypeptide drug production like Eptifibatide.
Analyzing patent CN101712716A for Vapreotide production. Highlights solid-phase iodine oxidation for higher yield and cost reduction in API manufacturing.
Patent CN114276411B reveals a solid-phase method for trisulfide cyclic peptides. Achieve high purity and yield with scalable manufacturing for pharmaceutical intermediates.
Patent CN108117565B reveals a novel solid-phase method for cefotaxime, offering superior purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Novel SPPS route for Setmelanotide offers >99% purity and scalable production for obesity treatment intermediates, ensuring reliable supply chain continuity.
Advanced solid-phase synthesis of Carbetocin improves yield and purity. Offers cost reduction in pharmaceutical intermediates manufacturing and supply reliability.
Novel Mmt protection and GSH oxidation system improves purity and yield for pharmaceutical intermediates manufacturing supply chain reliability and cost efficiency significantly.
Patent CN116120427B reveals high-yield solid-phase synthesis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Analysis of patent CN110903353B reveals a hybrid solid-liquid method for Bremelanotide, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel peptide synthesis method reduces impurities and enhances scalability for commercial Semaglutide production supply chains globally.
Patent CN111944016B details a novel solid-phase synthesis using nitro-protection and dipeptide fragments for high-purity icatibant acetate manufacturing.